Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.33 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19226624 | 1.00 | POLB (0.39) | POLBMEN1KMT2AALDH1A1EPHX1 | |
| SCHEMBL12158553 | 1.00 | POLB (0.39) | POLBMEN1KMT2AALDH1A1EPHX1 | |
| SCHEMBL21100159 | 0.92 | MAPT (0.33) | POLBMEN1KMT2AALDH1A1MAPT | |
| SCHEMBL21099805 | 0.92 | MAPT (0.33) | POLBMEN1KMT2AALDH1A1MAPT | |
| SCHEMBL800709 | 0.92 | — | — | |
| SCHEMBL13197315 | 0.92 | MAPT (0.33) | POLBMEN1KMT2AALDH1A1MAPT | |
| SCHEMBL12158539 | 0.88 | EPHX1 (0.41) | POLBMEN1KMT2AALDH1A1EPHX1 | |
| SCHEMBL10208134 | 0.88 | EPHX1 (0.41) | POLBMEN1KMT2AALDH1A1EPHX1 | |
| SCHEMBL16185847 | 0.82 | — | — | |
| SCHEMBL19592755 | 0.82 | LMNA (0.43) | KMT2ACYP2C19MAPTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12416114-B2 | Fabric spray containing lactilol for malodour reduction | CONIPCO, INC. (US) | 2025-09-16 | — | — | US | disclosed |
| EP-3694964-B1 | AQUEOUS SPRAY COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2025-08-06 | — | — | EP | disclosed |
| EP-3149143-B1 | USE OF POLYPEPTIDE | NOVOZYMES AS (DK) | 2025-08-06 | — | — | EP | disclosed |
| WO-2025078195-A1 | FABRIC SPRAY | UNILEVER IP HOLDINGS B.V. (NL) | 2025-04-17 | — | — | WO | disclosed |
| EP-3694965-B1 | AQUEOUS SPRAY COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2025-02-12 | — | — | EP | disclosed |
| CN-114901901-B | Fabric spray | 联合利华知识产权控股有限公司 | 2024-11-08 | — | — | CN | disclosed |
| EP-4278035-B1 | METHOD FOR SPRAYING LAUNDRY | UNILEVER IP HOLDINGS B V (NL) | 2024-10-23 | — | — | EP | disclosed |
| US-11987771-B2 | Fabric spray composition comprising a non-functionalized silicone nanoemulsion and peg-40 hydrogenated castor oil | CONOPCO, INC. (US) | 2024-05-21 | — | — | US | disclosed |
| US-20240141255-A1 | FABRIC SPRAY COMPOSITION | CONOPCO, INC., D/B/A UNILEVER (US) | 2024-05-02 | — | — | US | disclosed |
| EP-4211213-B1 | LAUNDRY SPRAY COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2024-04-03 | — | — | EP | disclosed |
| US-20030224030-A1 | Methods and articles for reducing airborne particulates | THE PROCTER & GAMBLE COMPANY | 2003-12-04 | — | — | US | disclosed |
| US-20030215417-A1 | Malodor-controlling compositions comprising odor control agents and microcapsules containing an active material | THE PROCTER & GAMBLE COMPANY | 2003-11-20 | — | — | US | disclosed |
| US-20030216488-A1 | Compositions comprising a dispersant and microcapsules containing an active material | THE PROCTER & GAMBLE COMPANY | 2003-11-20 | — | — | US | disclosed |
| WO-2003089019-A1 | MALODOR-CONTROLLING COMPOSITIONS COMPRISING ODOR CONTROL AGENTS AND MICROCAPSULES CONTAINING AN ACTIVE MATERIAL | THE PROCTER & GAMBLE COMPANY (US) | 2003-10-30 | — | — | WO | disclosed |
| WO-2003089561-A2 | COMPOSITIONS COMPRISING A DISPERSANT AND MICROCAPSULES CONTAINING AN ACTIVE MATERIAL | THE PROCTER & GAMBLE COMPANY (US) | 2003-10-30 | — | — | WO | disclosed |
| WO-2003086408-A1 | USE OF A2A ADENOSINE RECEPTOR AGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2003-10-23 | — | — | WO | disclosed |
| US-6432891-B1 | INTRODUCING INTO SOLID OR LIQUID, SOAP OR DETERGENT COMPOUND SELECTED FROM 1-CYCLOHEXYL-ETHYLBUTYRATE, 1-CYCLOHEXYL-ETHYLACETATE, 1-CYCLOHEXYL-ETHANOL, 4-ISOPROPYL-CYCLOHEXYLPROPIONATE | BUSH BOAKE ALLEN INC., | 2002-08-13 | — | — | US | disclosed |
| US-20020032131-A1 | Malodor counteractant compositions and methods for preparing and using same | BUSH BOAKE ALLEN INC. | 2002-03-14 | — | — | US | disclosed |
| EP-1167507-A2 | Malodor counteractant compositions and methods for preparing and using same | Bush Boake Allen Inc. (US) | 2002-01-02 | — | — | EP | disclosed |
| US-4187251-A | DEODORIZING, ALKYLCYCLOHEXYL ALKYL KETONES | SCHLEPPNIK ALFRED A | 1980-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030224030-A1 | Methods and articles for reducing airborne particulates | CUTA, EXOSC9, PPARA | POLB 216/4885MEN1 2725/4885KMT2A 4648/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.